Morepen Labs shares surge on record trading volumes

Morepen Laboratories shares traded at elevated levels on the National Stock Exchange and Bombay Stock Exchange Thursday, with combined trading volumes reaching 38.92 million shares by early afternoon. The surge in turnover underscored sustained investor appetite for the pharmaceutical company's stock.

The counter has demonstrated remarkable performance in recent months, recording gains of approximately 191 percent over a four-month period. This appreciation has been accompanied by a sharp increase in average daily trading volumes, with dealers noting transaction activity more than doubling from typical levels.

The elevated volumes reflect growing investor confidence in the stock, though analysts attributed the movement to broader market dynamics and sector-specific factors affecting pharmaceutical equities. Morepen Laboratories, a leading player in the domestic pharmaceutical sector, has maintained its presence across multiple therapeutic segments.

Trading data showed sustained interest from both retail and institutional participants, with the stock maintaining its upward trajectory throughout Thursday's session. Market observers noted that heightened liquidity often accompanies significant price movements, enabling investors to build or adjust positions more readily.